View in EDS

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.

Saved in:
Bibliographic Details
Title: A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.
Authors: Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medical Center, New York, USA. Electronic address: cns9006@med.cornell.edu., Saad F; Montreal Cancer Institute, Montreal University Hospital Center (CHUM), Montreal, QC, Canada., Graff JN; Knight Cancer Institute, Oregon Health and Science University and VA Portland Health Care System, Portland, USA., Peer A; Department of Oncology, Rambam Health Care Center, Haifa, Israel., Vaishampayan UN; Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, USA., Leung E; Division of Nuclear Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada., Rosenbaum E; Institute of Oncology, Rabin Medical Center-Davidoff Cancer Center, Petah Tikva, Israel., Gurney H; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia., Epstein RJ; Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia., Davis ID; Department of Medicine, Monash University, Melbourne, Australia; Eastern Health, Melbourne, Australia., Wu B; Clinical Statistics Oncology, Bayer HealthCare Pharmaceutical Inc, Whippany, USA., Trandafir L; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland., Wagner VJ; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland., Hussain M; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Feb; Vol. 31 (2), pp. 257-265. Date of Electronic Publication: 2019 Dec 23.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31959342
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sternberg+CN%22">Sternberg CN</searchLink>; Englander Institute for Precision Medicine, Weill Cornell Medical Center, New York, USA. Electronic address: cns9006@med.cornell.edu.<br /><searchLink fieldCode="AU" term="%22Saad+F%22">Saad F</searchLink>; Montreal Cancer Institute, Montreal University Hospital Center (CHUM), Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Graff+JN%22">Graff JN</searchLink>; Knight Cancer Institute, Oregon Health and Science University and VA Portland Health Care System, Portland, USA.<br /><searchLink fieldCode="AU" term="%22Peer+A%22">Peer A</searchLink>; Department of Oncology, Rambam Health Care Center, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Vaishampayan+UN%22">Vaishampayan UN</searchLink>; Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, USA.<br /><searchLink fieldCode="AU" term="%22Leung+E%22">Leung E</searchLink>; Division of Nuclear Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rosenbaum+E%22">Rosenbaum E</searchLink>; Institute of Oncology, Rabin Medical Center-Davidoff Cancer Center, Petah Tikva, Israel.<br /><searchLink fieldCode="AU" term="%22Gurney+H%22">Gurney H</searchLink>; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Epstein+RJ%22">Epstein RJ</searchLink>; Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Davis+ID%22">Davis ID</searchLink>; Department of Medicine, Monash University, Melbourne, Australia; Eastern Health, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Wu+B%22">Wu B</searchLink>; Clinical Statistics Oncology, Bayer HealthCare Pharmaceutical Inc, Whippany, USA.<br /><searchLink fieldCode="AU" term="%22Trandafir+L%22">Trandafir L</searchLink>; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wagner+VJ%22">Wagner VJ</searchLink>; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hussain+M%22">Hussain M</searchLink>; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2020 Feb; Vol. 31 (2), pp. 257-265. <i>Date of Electronic Publication: </i>2019 Dec 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31959342
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2019.10.025
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 257
    Titles:
      – TitleFull: A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sternberg CN
      – PersonEntity:
          Name:
            NameFull: Saad F
      – PersonEntity:
          Name:
            NameFull: Graff JN
      – PersonEntity:
          Name:
            NameFull: Peer A
      – PersonEntity:
          Name:
            NameFull: Vaishampayan UN
      – PersonEntity:
          Name:
            NameFull: Leung E
      – PersonEntity:
          Name:
            NameFull: Rosenbaum E
      – PersonEntity:
          Name:
            NameFull: Gurney H
      – PersonEntity:
          Name:
            NameFull: Epstein RJ
      – PersonEntity:
          Name:
            NameFull: Davis ID
      – PersonEntity:
          Name:
            NameFull: Wu B
      – PersonEntity:
          Name:
            NameFull: Trandafir L
      – PersonEntity:
          Name:
            NameFull: Wagner VJ
      – PersonEntity:
          Name:
            NameFull: Hussain M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2020 Feb
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1